Imai, K., Takai, K., Hanai, T., Suetsugu, A., Shiraki, M., & Shimizu, M. (2020). Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment. Mol Clin Oncol.
Citação norma ChicagoImai, Kenji, Koji Takai, Tatsunori Hanai, Atsushi Suetsugu, Makoto Shiraki, and Masahito Shimizu. "Sustained Virological Response By Direct-acting Antivirals Reduces the Recurrence Risk of Hepatitis C-related Hepatocellular Carcinoma After Curative Treatment." Mol Clin Oncol 2020.
Citação norma MLAImai, Kenji, et al. "Sustained Virological Response By Direct-acting Antivirals Reduces the Recurrence Risk of Hepatitis C-related Hepatocellular Carcinoma After Curative Treatment." Mol Clin Oncol 2020.